ISSN: 1755-5310 (Electronic)1755-5302 (Print)

Interventional Cardiology

Peer Reviewed Levodopa Journals

 Levodopa is that the precursor to monoamine neurotransmitter. Most typically, clinicians use L-dopa as a monoamine neurotransmitter replacement agent for the treatment of Parkinson sickness. It's most effectively wont to management bradykinetic symptoms that area unit apparent in Parkinson sickness. L-dopa, additionally referred to as L-dopa and l-3, 4-dihydroxyphenylalanine, is associate degree aminoalkanoic acid that's created and used as a part of the traditional biology of humans, further as some animals and plants. It is most effectively wont to management bradykinetic symptoms that area unit apparent in Parkinson sickness and it's the foremost effective medication to boost the standard of life in patients with upset Pd. L-dopa is often prescribed to a patient with Parkinson sickness once symptoms become harder to manage with alternative antiparkinsonian medication. The drug is additionally helpful for post encephalitic paralysis agitans and symptomatic paralysis agitans thanks to monoxide intoxication. Recent information have recommended that L-dopa will either hamper the progression of Parkinson sickness and/or have raised edges even when drug administration has stopped. A standard off-label use for L-dopa is restless leg syndrome and periodic limb movement in sleep (PLMS). L-dopa has been recommended as an inexpensive treatment choice for patients with intermittent restless leg syndrome United Nations agency don't want regular daily medical care.

High Impact List of Articles

Relevant Topics in Clinical